ARTICLE | Financial News
C-Bridge leads Nuance's series B
June 28, 2018 9:19 PM UTC
Nuance Biotech (Shanghai) Co. Ltd. (Shanghai, China) raised $20 million in a series B round led by C-Bridge Capital. Nuance is eligible to receive an additional $15 million from C-Bridge for acquiring new products.
Nuance has a portfolio of in-licensed assets that are already marketed or under review with China's State Drug Administration, as well as products in clinical development...